Data Foundry

Medical device recalls 2015

Alere i Influenza A & B Product Usage: The Alere i Influenza A and B… — Class II medical device recall Z-1677-2015

Terminated recall by Alere Scarborough, Inc. dba Binax, Inc., reported 2015-06-03, distributed nationwide. High invalid rate and an increased risk of false negative results with certain lots of the Alere i Influenza A

Recall numberZ-1677-2015
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAlere Scarborough, Inc. dba Binax, Inc., Scarborough, ME, United States
Recall initiated2015-04-22
Classified2015-05-27
Reported by FDA2015-06-03
Terminated2016-01-14
DistributedNationwide (US)
Countries outside the USHK, SG

Product

Alere i Influenza A & B Product Usage: The Alere i Influenza A and B assay, performed on the Alere i Instrument, is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology for the qualitative detection and discrimination of influenza A and B viral RNA in nasal swabs from patients with signs and symptoms of respiratory infection. It is intended for use as an aid in the differential diagnosis of influenza A and B viral infections in humans, in conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenza C virus.

Reason for recall

High invalid rate and an increased risk of false negative results with certain lots of the Alere i Influenza A & B kit.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1677-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.